Glucuronolactone Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

List of Tables

The global glucuronolactone market is anticipated to reach $6,17,293.3 thousand by 2032, growing from $3,80,308.6 thousand in 2022 at a CAGR of 5.2% from 2023 to 2032.

Glucuronolactone is a chemical found in food products and is also manufactured in laboratories. Glucuronolactone is used as an ingredient in various consumer products, including some energy drinks, dietary supplements, and functional beverages... Glucuronolactone is included in supplements alongside taurine and caffeine. It can also be used in conjunction with other pre-workout substances like as creatine, beta-alanine, and citrulline. Glucuronolactone is a common ingredient found in many energy drinks such as Red bull and a number of pre-workout supplements, and fat-loss proteins, and it is found to increase bodily strength and intellectual focus.

A growing sedentary lifestyle and consumption of an unhealthy diet are driving market growth. The increasing demand for immediate energy-releasing products such as Rockstar, Red Bull, and Monster has contributed to market expansion. Furthermore, increased demand for clean-label and plant-based goods, as well as a growing inclination for a healthy, active lifestyle, are predicted to drive market expansion throughout the projection period. Furthermore, the increased usage of social media platforms such as Instagram and YouTube by manufacturers to advertise sports items is likely to drive market expansion throughout the forecast period by increasing the popularity of products. Moreover, the increasing disposable income of the consumers, and rising focus on sports nutrition encourage new product development, coupled with the rising awareness of sports nutrition.

The high glucuronolactone prices and different adverse impacts of excessive glucuronolactone intake, like disorientation, dizziness, and fast heartbeat, are expected to hamper market growth. The regulatory landscape surrounding dietary supplements and functional ingredients like glucuronolactone is evolving. Governments and regulatory bodies are placing greater emphasis on safety, efficacy, and accurate labeling. As regulations become more stringent, companies operating in the glucuronolactone market might face challenges in obtaining the necessary approvals and certifications for their products. These regulatory hurdles can lead to delays in product launches and additional costs associated with compliance, hindering the growth prospects of the market.

Rising pharmaceutical investments are contributing to the glucuronolactone industry's expansion. This can be due to the growing use of glucuronolactone in medicine manufacture, where it is employed as an addition to preserve uniformity and other properties. Rising innovation by key companies in glucuronolactone is expected to drive market growth. For instance, on 28 March 2019, to compete directly with market leaders Coca Cola launched its first energy drink in the United Kingdom, driving demand for glucuronolactone. The new drink, which contains caffeine, glucuronolactone, guarana extracts, and B vitamins, is intended for those aged 18 to 35.

The COVID-19 pandemic has had significant impacts on the market for glucuronolactone, influencing various aspects of its dynamics. Supply chain disruptions emerged as a significant challenge, with lockdowns, restrictions on travel, and reduced workforce availability affecting the sourcing of raw materials necessary for glucuronolactone production. These disruptions, combined with manufacturing facility closures and reduced operational capacities due to health and safety protocols, led to production slowdowns and potential shortages of glucuronolactone-containing products. The pandemic-induced shift in consumer behavior towards health and wellness further influenced the demand for dietary supplements and functional ingredients like glucuronolactone. With consumers increasingly seeking products that support immunity and overall well-being, the market experienced fluctuations in demand. Additionally, the closure of physical retail outlets prompted a greater reliance on online sales channels for distributing products, accelerating the trend towards e-commerce within the industry.

The key players profiled in this report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., Roquette Freres. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the glucuronolactone market analysis from 2022 to 2032 to identify the prevailing glucuronolactone market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the glucuronolactone market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global glucuronolactone market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Investment Opportunities
Supply Chain Analysis & Vendor Margins
Technology Trend Analysis
Consumer Preference and Product Specifications
Market share analysis of players by products/segments
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Criss-cross segment analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Market share analysis of players at global/region/country level
SWOT Analysis

Key Market Segments

By Type

Powder
Liquid
Tablet/Capsule

By Application

Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements

By End User

Food and Beverages
Pharmaceuticals

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of LAMEA

Key Market Players:

Jungbunzlauer
Shandong Xinhong Pharmaceutical Co., Ltd.
Shandong Fuyuan Bio-Tech CO.LTD.
Merck Millipore Corporation
Shaoxing Marina Biotechnology Co.Ltd.
Shandong Baisheng Biotechnology Co., Ltd.
Roquette Freres
Functional Food chem International Corporation
Hubei Yitai Pharmaceutical Co.Ltd.
Anhui Fubore Pharmaceutical & Chemical Co.Ltd.

Product Code: A13550

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
3.5. Average Selling Price
3.6. Market Share Analysis
3.7. Brand Share Analysis
3.8. Trade Data Analysis
3.9. Product Consumption
3.10. Value Chain Analysis
3.11. Regulatory Guidelines
3.12. Key Regulation Analysis
3.13. Reimbursement Scenario
3.14. Patent Landscape

CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Powder
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Liquid
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Tablet/Capsule
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Preservatives
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Antioxidants
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Processing Aids and Additives
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Energy Supplements
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Food and Beverages
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Pharmaceuticals
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country

CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Type
  - 7.2.5.1.2. Market size and forecast, by Application
  - 7.2.5.1.3. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Type
  - 7.2.5.2.2. Market size and forecast, by Application
  - 7.2.5.2.3. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Type
  - 7.2.5.3.2. Market size and forecast, by Application
  - 7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Type
  - 7.3.5.1.2. Market size and forecast, by Application
  - 7.3.5.1.3. Market size and forecast, by End User
  - 7.3.5.2. UK
  - 7.3.5.2.1. Market size and forecast, by Type
  - 7.3.5.2.2. Market size and forecast, by Application
  - 7.3.5.2.3. Market size and forecast, by End User
  - 7.3.5.3. France
  - 7.3.5.3.1. Market size and forecast, by Type
  - 7.3.5.3.2. Market size and forecast, by Application
  - 7.3.5.3.3. Market size and forecast, by End User
  - 7.3.5.4. Spain
  - 7.3.5.4.1. Market size and forecast, by Type
  - 7.3.5.4.2. Market size and forecast, by Application
  - 7.3.5.4.3. Market size and forecast, by End User
  - 7.3.5.5. Italy
  - 7.3.5.5.1. Market size and forecast, by Type
  - 7.3.5.5.2. Market size and forecast, by Application
  - 7.3.5.5.3. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Type
  - 7.3.5.6.2. Market size and forecast, by Application
  - 7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. China
  - 7.4.5.1.1. Market size and forecast, by Type
  - 7.4.5.1.2. Market size and forecast, by Application
  - 7.4.5.1.3. Market size and forecast, by End User
  - 7.4.5.2. Japan
  - 7.4.5.2.1. Market size and forecast, by Type
  - 7.4.5.2.2. Market size and forecast, by Application
  - 7.4.5.2.3. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Type
  - 7.4.5.3.2. Market size and forecast, by Application
  - 7.4.5.3.3. Market size and forecast, by End User
  - 7.4.5.4. South Korea
  - 7.4.5.4.1. Market size and forecast, by Type
  - 7.4.5.4.2. Market size and forecast, by Application
  - 7.4.5.4.3. Market size and forecast, by End User
  - 7.4.5.5. Australia
  - 7.4.5.5.1. Market size and forecast, by Type
  - 7.4.5.5.2. Market size and forecast, by Application
  - 7.4.5.5.3. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Type
  - 7.4.5.6.2. Market size and forecast, by Application
  - 7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Type
  - 7.5.5.1.2. Market size and forecast, by Application
  - 7.5.5.1.3. Market size and forecast, by End User
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Market size and forecast, by Type
  - 7.5.5.2.2. Market size and forecast, by Application
  - 7.5.5.2.3. Market size and forecast, by End User
  - 7.5.5.3. United Arab Emirates
  - 7.5.5.3.1. Market size and forecast, by Type
  - 7.5.5.3.2. Market size and forecast, by Application
  - 7.5.5.3.3. Market size and forecast, by End User
  - 7.5.5.4. South Africa
  - 7.5.5.4.1. Market size and forecast, by Type
  - 7.5.5.4.2. Market size and forecast, by Application
  - 7.5.5.4.3. Market size and forecast, by End User
  - 7.5.5.5. Rest of LAMEA
  - 7.5.5.5.1. Market size and forecast, by Type
  - 7.5.5.5.2. Market size and forecast, by Application
  - 7.5.5.5.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Jungbunzlauer
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
9.2. Shandong Xinhong Pharmaceutical Co., Ltd.
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
9.3. Shandong Fuyuan Bio-Tech CO.LTD.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
9.4. Merck Millipore Corporation
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
9.5. Shaoxing Marina Biotechnology Co.Ltd.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
9.6. Shandong Baisheng Biotechnology Co., Ltd.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
9.7. Roquette Freres
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
9.8. Functional Food chem International Corporation
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
9.9. Hubei Yitai Pharmaceutical Co.Ltd.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
9.10. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot